SMAD4 and hereditary hemorrhagic telangiectasia: However, ~15% of clinically diagnosed HHT patients do not show mutations in the coding regions or exon/intron junctions of ACVRL1, ENG, or SMAD4, in spite of the fact that in some families, linkage analyses suggest ACVRL1 or ENG to be the causative gene [10, 25].